07:00 , Sep 18, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease ...
07:00 , Jun 26, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/ marker/pathway Summary Licensing status Publication and contact information Autoimmune disease ...
08:00 , Mar 27, 2006 |  BC Week In Review  |  Company News

Advanced Biotherapy, Battelle Memorial Institute deal

ADVB and the institute signed a memorandum of understanding to develop antibodies to treat anthrax and plague. Further terms were not disclosed. Advanced Biotherapy Inc. (ADVB), Woodland Hills, Calif.   Battelle Memorial Institute, Columbus, Ohio   Business:...
08:00 , Jan 2, 2006 |  BC Week In Review  |  Company News

Advanced Biotherapy scientific advisory board update

Advanced Biotherapy Inc. (ADVB), Woodland Hills, Calif.   Business: Autoimmune, Infectious   Appointed: Daniel Levitt, CMO and head of clinical and regulatory affairs at Dynavax Technologies Corp.   ...
08:00 , Mar 21, 2005 |  BC Week In Review  |  Clinical News

TNF alpha inhibitor: Preliminary Phase I data

Preliminary data from an open-label Phase I trial in 10 patients showed that TNF alpha inhibitor led to a decrease in viral load. Advanced Biotherapy Inc. (ADVB), Woodland Hills, Calif.   Product: TNF alpha inhibitor...
08:00 , Mar 7, 2005 |  BC Week In Review  |  Company News

Advanced Biotherapy scientific advisory board update

Advanced Biotherapy Inc. (ADVB), Woodland Hills, Calif.   Business: Autoimmune   Appointed: Yehuda Shoenfeld, former professor at Tel-Aviv University   ...
08:00 , Jan 24, 2005 |  BC Week In Review  |  Clinical News

Anti-interferon gamma infectious data

Data from an open-label, Russian trial in less than 10 patients showed that treatment with topical anti-IFNg antibodies for several days helped relieve itching and pain within hours while the eroded area of the skin...
07:00 , Oct 18, 2004 |  BC Week In Review  |  Clinical News

Anti-interferon gamma: Pilot trial data

In an open-label, Russian Pilot study in patients who were unresponsive to standard treatment, anti-IFNg antibodies gave rapid reduction of burning and pain around the lesions. Advanced Biotherapy Inc. (ADVB), Woodland Hills, Calif.   Product: Anti-interferon...
07:00 , May 10, 2004 |  BC Week In Review  |  Company News

Advanced Biotherapy, Innogenetics NV deal

INNX and ADVB cross-licensed their respective interferon gamma IP related to various autoimmune diseases. The deal initially will cover applications in rheumatoid arthritis (RA), with an option to include other autoimmune diseases. The deal enables...
07:00 , May 5, 2004 |  BC Extra  |  Company News

INNX, Advanced Biotherapy interferon gamma deal

Innogenetics (Euronext: INNX) and ADVB cross-licensed their respective interferon gamma IP related to various autoimmune diseases. The deal initially will cover rheumatoid arthritis (RA). The companies will share proceeds from the combined IP. INNX is...